Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
J Clin Oncol. 2024 Sep 30:JCO2301867. doi: 10.1200/JCO.23.01867. Online ahead of print. ABSTRACT PURPOSE: Current clinical challenges in Hodgkin lymphoma (HL) include difficult-to-treat relapsed/refractory disease …